Seen Sophia, Young Stephanie Ming, Teo Shao Jin, Lang Stephanie S, Amrith Shantha, Lim Thiam-Chye, Sundar Gangadhara
Yong Loo Lin School of Medicine, National University of Singapore.
Orbit and Oculofacial Surgery, Department of Ophthalmology, National University Hospital Singapore.
Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):536-543. doi: 10.1097/IOP.0000000000001077.
To compare the outcomes of bioresorbable and permanent implants in the reconstruction of isolated orbital floor blowout fractures.
Retrospective series of all patients who had orbital floor fracture repair in a single tertiary trauma center from January 2005 to December 2014. The authors reviewed the case notes and CT scans of patients with orbital floor fracture repair with either bioresorbable or permanent implants. Main outcome measures were enophthalmos, diplopia, and ocular motility restriction 1.5 years after fracture repair. Implant-related complications were collected for analysis.
There were a total of 88 patients in our study. Bioresorbable implants were used in 48 patients (54.5%) while 40 patients had permanent implants (45.5%). The authors analyzed the implants used in various sizes of orbital fractures: small (<13.3 mm), medium (13.3-20 mm), and large (>20 mm). One and a half years after fracture repair, both groups had comparable clinical outcomes (n = 2 and n = 0 for diplopia for permanent and bioresorbable implant groups, respectively, n = 0 for enophthalmos for both groups and n = 1 for ocular motility limitation for both groups) overall and across all fracture sizes.
Bioresorbable implants degrade after fracture healing through hydrolysis and promote the gradual transfer of functional forces to healing bone during its disintegration. The clinical outcomes of diplopia, enophthalmos, and ocular motility restriction associated with the use of resorbable implants are comparable to that of permanent implants for all fracture sizes. Their study shows that bioresorbable and permanent implants are equally safe and effective for the treatment of patients with isolated orbital floor blowout fractures.
比较生物可吸收植入物和永久性植入物在孤立性眶底爆裂骨折重建中的效果。
回顾性研究2005年1月至2014年12月在单一三级创伤中心接受眶底骨折修复的所有患者。作者查阅了使用生物可吸收或永久性植入物进行眶底骨折修复患者的病历和CT扫描。主要观察指标为骨折修复1.5年后的眼球内陷、复视和眼球运动受限情况。收集植入物相关并发症进行分析。
本研究共有88例患者。48例患者(54.5%)使用了生物可吸收植入物,40例患者(45.5%)使用了永久性植入物。作者分析了用于各种大小眶骨折的植入物:小(<13.3毫米)、中(13.3 - 20毫米)和大(>20毫米)。骨折修复1.5年后,两组总体及所有骨折大小的临床效果相当(永久性植入物组和生物可吸收植入物组复视分别为n = 2和n = 0,两组眼球内陷均为n = 0,两组眼球运动受限均为n = 1)。
生物可吸收植入物在骨折愈合后通过水解降解,并在其分解过程中促进功能力逐渐转移至愈合的骨。与使用可吸收植入物相关的复视、眼球内陷和眼球运动受限的临床效果与所有骨折大小的永久性植入物相当。他们的研究表明,生物可吸收和永久性植入物在治疗孤立性眶底爆裂骨折患者方面同样安全有效。